Jasper Therapeutics Inc (JSPR)

Jasper Therapeutics Inc (JSPR) 財務データ

損益計算書

四半期ごと

*すべての数値は百万単位です

期間終了日	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	100.00% -	-0.118	0.051	-0.109	-0.07
Operating Expenses	14.97% 15.07	17.73	19.36	17.83	13.95
Depreciation and Amortization	0.288	-	-	0.275	0.274
Operating Income/Loss	14.97% -15.07	-17.73	-19.36	-17.83	-13.95
Nonoperating Income/Loss	1.344	-	-	-	-
Income/Loss From Continuing Operations Before Tax	11,534% -13.73	-0.118	0.051	-16.08	-14.26
Income/Loss From Continuing Operations After Tax	17.21% -13.73	-16.58	-17.54	-16.08	-14.26
Net Income/Loss	17.21% -13.73	-16.58	-17.54	16.10	-14.26
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	114.51% 13.33	-91.91	109.72	109.21	88.16
Diluted Average Shares	114.51% 13.33	-91.91	109.72	109.21	88.16
Basic Earnings Per Share	81.96% -1.03	-5.71	-0.16	-0.15	-0.16
Diluted Earnings Per Share	81.96% -1.03	-5.71	-0.16	-0.15	-0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-